Management of childhood epilepsy has been proven to have different issues from those in adults, primarily related to the growth and development processes that may affect or be affected by epilepsy treatment. In addition, epilepsy in childhood is more varied than epilepsy in adults and includes many different syndromes (many qualifying as rare diseases), most of which exhibit a different clinical course and respond differently to therapy.
Meridian is now conducting a clinical research study for an investigational medication for children with epilepsy.
- Must be older than 1 month and younger than 18 years
- Must be diagnosed with epilepsy
- Must currently take at least 1 and as many as 4 anti-elliptic drugs
- Will receive study-related care and exams at no cost
- Do not need insurance to join this study
- Must meet all inclusion criteria
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.
Meridian Clinical Research
6602 Waters Avenue, Building C
Savannah, GA 31406
Sign up for more information...
About Meridian Clinical Research
Founded in 1999, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services.
Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For almost 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.